e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
The vulnerable patient and ageing cells
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Telomere length in chronic obstructive pulmonary disease
E. Sobh, M. Galal, E. Sayed, M. Hilmy Alryes, M. Refaat, A. Ashmawy (Cairo, Egypt)
Source:
Annual Congress 2013 –The vulnerable patient and ageing cells
Session:
The vulnerable patient and ageing cells
Session type:
Thematic Poster Session
Number:
639
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Sobh, M. Galal, E. Sayed, M. Hilmy Alryes, M. Refaat, A. Ashmawy (Cairo, Egypt). Telomere length in chronic obstructive pulmonary disease. Eur Respir J 2013; 42: Suppl. 57, 639
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Dysregulation of serum miRNA in chronic obstructive pulmonary disease
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Endotelialny dysfunction at patients with COPD and coronary heart disease
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Survivin in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Structural brain changes in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Polymorphism of collagen I gene and risk of chronic obstructive pulmonary disease associated with ischemic heart disease
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Case control study of chronic obstructive pulmonary disease and its progression
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Telomere shortening in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Year: 2008
The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Inflammatory gene polymorphisms in asthma and chronic obstructive pulmonary disease in Venezuela
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Common airway variants and chronic obstructive pulmonary disease
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015
A possible role of Krüppel-like factor 5 in small airway wall fibrosis in COPD
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Accelerated ageing and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept